As part of our commitment to effective treatment, we offer guidance on injectable medications like Ozempic and tirzepatide, both of which are at the forefront of diabetes management
In that environment of uncertainty comes a new study published last Thursday in JAMA Ophthalmology demonstrating that more than twice as many patients with diabetes exposed to GLP-1 agonists developed neovascular age-related macular degeneration (wet AMD) compared with those in a matched cohort of similar patients who were unexposed
To mitigate misinterpretation, individuals with stage 5 chronic kidney disease (CKD), with end-stage kidney disease (ESKD), or receiving dialysis at baseline were excluded from the major adverse kidney event (MAKE) outcome analysis
Koca, H., Bor, M., Ozdemir, F
however, a distinction from therapeutic plasmapheresis has to be made